BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Qamar AA, Grace ND. Abnormal hematological indices in cirrhosis. Can J Gastroenterol 2009;23:441-5. [PMID: 19543577 DOI: 10.1155/2009/591317] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Shao YY, Huang CC, Liang PC, Lin ZZ. Hepatic arterial infusion of chemotherapy for advanced hepatocellular carcinoma. Asia Pac J Clin Oncol 2010;6:80-8. [PMID: 20565419 DOI: 10.1111/j.1743-7563.2010.01287.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
2 Young S, Kwarta E, Azzam R, Sentongo T. Nutrition assessment and support in children with end-stage liver disease. Nutr Clin Pract. 2013;28:317-329. [PMID: 23466471 DOI: 10.1177/0884533612474043] [Cited by in Crossref: 37] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
3 Ferri S, Lalanne C, Lanzoni G, Bassi M, Asioli S, Cipriano V, Pappas G, Muratori P, Lenzi M, Muratori L. Redistribution of regulatory T-cells across the evolving stages of chronic hepatitis C. Dig Liver Dis 2011;43:807-13. [PMID: 21684822 DOI: 10.1016/j.dld.2011.04.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
4 Gao B, Wang D, Ma W, Jia X, Ma B, Zhang W, Xue D. MicroRNA-mRNA regulatory network study and apoptosis analysis on bone marrow endothelial cells induced by liver cirrhosis serum. Clin Res Hepatol Gastroenterol 2014;38:451-61. [PMID: 24972801 DOI: 10.1016/j.clinre.2013.09.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
5 Pradhan-Sundd T, Gudapati S, Kaminski TW, Ragni MV. Exploring the Complex Role of Coagulation Factor VIII in Chronic Liver Disease. Cell Mol Gastroenterol Hepatol 2021;12:1061-72. [PMID: 33705963 DOI: 10.1016/j.jcmgh.2021.02.014] [Reference Citation Analysis]
6 Raffa GA, Byrnes DM, Byrnes JJ. The Diagnosis Is in the Smear: A Case and Review of Spur Cell Anemia in Cirrhosis. Case Rep Hematol 2021;2021:8883335. [PMID: 33854804 DOI: 10.1155/2021/8883335] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Rajakumar A, Appuswamy E, Kaliamoorthy I, Rela M. Renal Dysfunction in Cirrhosis: Critical Care Management. Indian J Crit Care Med 2021;25:207-14. [PMID: 33707901 DOI: 10.5005/jp-journals-10071-23721] [Reference Citation Analysis]
8 Hadduck TA, McWilliams JP. Partial splenic artery embolization in cirrhotic patients. World J Radiol 2014; 6(5): 160-168 [PMID: 24876920 DOI: 10.4329/wjr.v6.i5.160] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 31] [Article Influence: 5.9] [Reference Citation Analysis]
9 Suvak B, Torun S, Tas A, Beyazit Y. Mean platelet volume is a useful indicator of systemic inflammation in cirrhotic patients with ascitic fluid infection. Annals of Hepatology 2014;13:573. [DOI: 10.1016/s1665-2681(19)31261-x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
10 Assal F, El Kassas M, Esmail E, Elbadry AA, Abousaif S, Mahdy R, Elfert A. Microwave ablation in the spleen versus partial splenic artery embolisation: A new technique for hypersplenism in cirrhosis. Arab J Gastroenterol 2017;18:25-9. [PMID: 28256406 DOI: 10.1016/j.ajg.2017.01.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
11 Park J, Lee SH, Gwak MS, Ko JS, Han S, Choi GS, Joh JW, Kim J, Kim GS. Association between neutrophil-lymphocyte ratio change during living donor liver transplantation and graft survival. Sci Rep 2021;11:4199. [PMID: 33603124 DOI: 10.1038/s41598-021-83814-9] [Reference Citation Analysis]
12 Barton JC, Barton JC, Acton RT. White blood cells and subtypes in HFE p.C282Y and wild-type homozygotes in the Hemochromatosis and Iron Overload Screening Study. Blood Cells, Molecules, and Diseases 2017;63:9-14. [DOI: 10.1016/j.bcmd.2016.11.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Miki K, Maruki T, Imashuku S. Plasmapheresis for Spur Cell Anemia in a Patient with Alcoholic Liver Cirrhosis. Case Rep Hematol 2018;2018:9513946. [PMID: 30034891 DOI: 10.1155/2018/9513946] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Gao B, Li ZT, Xue DB, Zhang WH. A novel mechanism of abnormal hematological indices in liver cirrhosis: bone marrow endothelial cell dysfunction caused by humoral inhibitor affects the hematopoietic function of bone marrow. Med Hypotheses 2014;82:282-5. [PMID: 24388557 DOI: 10.1016/j.mehy.2013.12.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
15 El Kassas M, Abdelkader H, Medhat MA. COVID-19 in Egypt: Through crisis to adaptation; a gastroenterologist's perspective. Arab J Gastroenterol. 2020;21:207-210. [PMID: 32798187 DOI: 10.1016/j.ajg.2020.07.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Montagnese S, Lauridsen M, Vilstrup H, Zarantonello L, Lakner G, Fitilev S, Zupanets I, Kozlova I, Bunkova E, Tomasiewicz K, Berglund JE, Rorsman F, Hagström H, Kechagias S, Ocklind CE, Mauney J, Thunarf F, Mokhatarani M, Bäckström T, Doverskog M, Lins LE, Månsson M, Samuelson P, Nilsson D, Schalling M, Johansson M, Arlander E, Scharschmidt BF. A pilot study of golexanolone, a new GABA-A receptor-modulating steroid antagonist, in patients with covert hepatic encephalopathy. J Hepatol 2021;75:98-107. [PMID: 33894327 DOI: 10.1016/j.jhep.2021.03.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
17 Kalambokis GN, Mouzaki A, Rodi M, Tsianos EV. Rifaximin improves thrombocytopenia in patients with alcoholic cirrhosis in association with reduction of endotoxaemia. Liver Int. 2012;32:467-475. [PMID: 22098272 DOI: 10.1111/j.1478-3231.2011.02650.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
18 Buoro S, Seghezzi M, Vavassori M, Dominoni P, Apassiti Esposito S, Manenti B, Mecca T, Marchesi G, Castellucci E, Azzarà G, Ottomano C, Lippi G. Clinical significance of cell population data (CPD) on Sysmex XN-9000 in septic patients with our without liver impairment. Ann Transl Med 2016;4:418. [PMID: 27942509 DOI: 10.21037/atm.2016.10.73] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
19 Bryan LJ, Zakai NA. Why is My Patient Anemic? Hematology/Oncology Clinics of North America 2012;26:205-30. [DOI: 10.1016/j.hoc.2012.02.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
20 Gaspari R, Teofili L, Mignani V, Franco A, Valentini CG, Cutuli SL, Cina A, Agnes S, Avolio AW, Antonelli M. Duplex Doppler evidence of high hepatic artery resistive index after liver transplantation: Role of portal hypertension and clinical impact. Digestive and Liver Disease 2020;52:301-7. [DOI: 10.1016/j.dld.2019.10.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]